CD40 Ligand-Modified Chimeric Antigen Receptor T Cells Enhance Antitumor Function by Eliciting an Endogenous Antitumor Response

Nicholas F. Kuhn(Memorial Sloan Kettering Cancer Center), Terence J. Purdon(Memorial Sloan Kettering Cancer Center), Dayenne G. van Leeuwen(Memorial Sloan Kettering Cancer Center), Andrea V. Lopez(Memorial Sloan Kettering Cancer Center), Kevin J. Curran(Memorial Sloan Kettering Cancer Center), Anthony F. Daniyan(Memorial Sloan Kettering Cancer Center), Renier J. Brentjens(Memorial Sloan Kettering Cancer Center)
Cancer Cell
March 1, 2019
10.1016/j.ccell.2019.02.006
Cited by 236Open Access
Full Text

Abstract

Related Papers

No related papers found

Powered by citation graph analysis